CBT
CABOT CORP
NYSE · Basic Materials · Chemicals - Specialty · US
$75.11
+4.32%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.7B | 3.7B | 3.7B | 4.0B | 3.9B |
| Cost of Revenue | 2.9B | 2.9B | 2.8B | 3.0B | 3.1B |
| Gross Profit | 816.0M | 809.0M | 940.0M | 960.0M | 839.0M |
| Operating Expenses | |||||
| R&D Expense | 54.0M | 54.0M | 59.0M | 63.0M | 57.0M |
| SG&A Expense | 278.0M | 278.0M | 260.0M | 283.0M | 253.0M |
| General & Admin Expense | 69.0M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (1.0M) | — | — | — | 3.0M |
| Total Operating Expenses | 331.0M | 332.0M | 319.0M | 346.0M | 313.0M |
| Cost and Expenses | 3.3B | 3.3B | 3.1B | 3.4B | 3.4B |
| Operating Income (EBIT) | 485.0M | 477.0M | 621.0M | 614.0M | 526.0M |
| Non-Operating | |||||
| Interest Income | 29.0M | 29.0M | 27.0M | 32.0M | 31.0M |
| Interest Expense | 76.0M | 75.0M | 76.0M | 81.0M | 90.0M |
| Net Interest Income | (47.0M) | (46.0M) | (49.0M) | (49.0M) | (59.0M) |
| Other Non-Op Income/Expense | (74.0M) | (65.0M) | (49.0M) | (79.0M) | (70.0M) |
| Non-Operating Income (excl Interest) | (21.0M) | — | (19.0M) | 4.0M | (15.0M) |
| EBT (Pre-Tax Income) | 411.0M | 412.0M | 572.0M | 535.0M | 456.0M |
| Income Tax Expense | 165.0M | 165.0M | 196.0M | 111.0M | (28.0M) |
| Bottom Line | |||||
| Net Income | 213.0M | 213.0M | 331.0M | 380.0M | 445.0M |
| Earnings from Cont. Ops | 246.0M | 247.0M | 376.0M | 424.0M | 484.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 213.0M | 213.0M | 331.0M | 374.0M | 437.0M |
| Per Share | |||||
| Basic EPS | $4.08 | $4.10 | $6.07 | $6.79 | $7.79 |
| Diluted EPS | $4.05 | $4.02 | $6.02 | $6.72 | $7.73 |
| Revenue Per Share | $72.70 | $72.14 | $69.14 | $73.56 | $71.16 |
| Shares | |||||
| Basic Shares Outstanding | 51.5M | 51.9M | 53.7M | 54.3M | 55.2M |
| Diluted Shares Outstanding | 51.9M | 52.2M | 54.2M | 55.7M | 56.5M |
| Profitability Metrics | |||||
| EBITDA | 697.0M | 668.0M | 794.0M | 761.0M | 685.0M |
| D&A | 191.0M | 191.0M | 154.0M | 151.0M | 144.0M |
| EBIT | 506.0M | 477.0M | 640.0M | 610.0M | 541.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026